title: Protein kinase C delta mediates platelet-induced breast cancer cell invasion.
abstract: Platelets play an important role in carcinogenesis, but the underlying molecular mechanisms remain poorly understood. To investigate the effects of platelets on in vitro invasion of MCF7 human breast cancer cells, human MCF7 cells were used to study their interactions with platelets using aggregometry and cell invasion chambers. Zymography and quantitative polymerase chain reaction (PCR) were used to study matrix metalloproteinases (MMPs), whereas Western blot was used to study protein kinase C (PKC) delta in MCF7 cells. We observed that platelets promoted invasion of MCF7 cells (3-fold increase, p<0.05, n=3) and that this process correlated with a dramatic increase in MMP-9 (8 fold-increase, p<0.001, n=3), which is known to facilitate cancer cell invasion. Because both platelets and MCF7 cells have been shown to release MMP-9, we investigated the cellular source that accounted for this increase. The time course and the use of specific protein synthesis inhibitors demonstrated that most of the increase in MMP-9 levels derived from de novo synthesis of this protease by cancer cells. Furthermore, platelets activated PKCdelta in MCF7 cells after 1 h of incubation (18.45+/-4.75% increase, p<0.05, n=4-7), which, in turn, led to an up-regulation of MMP-9 mRNA (from 60+/-20 to 1040+/-100 pg, p<0.001, n=3) and protein levels (18-fold increase, p<0.001, n=3), with the subsequent cell invasion-promoting effects. PKCdelta plays a crucial role in transducing the invasion-promoting effects of platelets in breast cancer cells, and the specific inhibition of PKCdelta may be a strategy to decrease platelet-mediated cancer cell invasion.
authors.affiliation: Department of Integrative Biology and Pharmacology, Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas, Houston, USA.
authors.forename: David
authors.initials: D
authors.lastname: Alonso-Escolano
authors.forename: Carlos
authors.initials: C
authors.lastname: Medina
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Cieslik
authors.forename: Anna
authors.initials: A
authors.lastname: Radomski
authors.forename: Paul
authors.initials: P
authors.lastname: Jurasz
authors.forename: Maria José
authors.initials: MJ
authors.lastname: Santos-Martínez
authors.forename: Tilahum
authors.initials: T
authors.lastname: Jiffar
authors.forename: Peter
authors.initials: P
authors.lastname: Ruvolo
authors.forename: Marek W
authors.initials: MW
authors.lastname: Radomski
mesh_terms: D001792:Blood Platelets / Q000201:enzymology*; D001943:Breast Neoplasms / Q000201:enzymology* / Q000473:pathology*; D018938:Caco-2 Cells; D006801:Humans; D009361:Neoplasm Invasiveness; D051745:Protein Kinase C-delta / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D047428:Protein Kinase Inhibitors; D051745:Protein Kinase C-delta